Selective targeting of signet ring cell adenocarcinomas
Yükleniyor...
Dosyalar
Tarih
2019
Yazarlar
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Yayıncı
Churchill Livingstone
Erişim Hakkı
info:eu-repo/semantics/closedAccess
Özet
Many epithelial tumors, especially signet-ring cell adenocarcinomas, produce huge amounts of mucin glycoproteins that fill cytoplasm and push nucleus to the periphery, giving a signet ring like structure to the cell. Mucin proteins are very rich of l-threonine which is essential in humans. L-threonine content can reach up to 35% of total amino acid composition of some mucin proteins. Therefore l-threonine can be the Achilles heel of signet ring cell adenocarcinomas which are one of the most malignant and agressive cancers. A modified bioisoster of l-threonine, 4-fluoro l-threonine (its fluorine can be radioactive or not), can be used to selectively kill signet ring cancer cells without harming normal cells or for diagnostic purposes.
Açıklama
Anahtar Kelimeler
Signet-Ring Cell Cancer, Mucin Proteins, 4-Fluoro L-Threonine, Systemic Radiotherapy
Kaynak
Medical Hypotheses
WoS Q Değeri
Q4
Scopus Q Değeri
Q2
Cilt
133
Sayı
Künye
Olgun, A. (2019). Selective targeting of signet ring cell adenocarcinomas. MEDICAL HYPOTHESES, 133. https://doi.org/10.1016/j.mehy.2019.109380
